PAIGE MCNASH: Open Payments
NPI 1083323752 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,773 in 144 payments from 20 companies in 2025. Trend: 2023 $2,105 · 2024 $3,141 · 2025 $4,773
Food & beverage: $3,423Consulting: $1,350
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $1,568 |
| ABBVIE INC. | 39 | $929 |
| Madrigal Pharmaceuticals | 11 | $324 |
| Lilly USA, LLC | 9 | $302 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $258 |
| GENZYME CORPORATION | 7 | $201 |
| PFIZER INC. | 10 | $189 |
| Gilead Sciences, Inc. | 9 | $158 |
| Phathom Pharmaceuticals, Inc. | 9 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $115 |
Products named: TREMFYA, CREON, REZDIFFRA, RINVOQ, XIFAXAN, DUPIXENT, LINZESS, OMVOH.
Industry payments across FL — which companies pay providers there.
